Charles Minard
Overview
Explore the profile of Charles Minard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Davis C, Anagnostou A, Devaraj S, Vita D, Rivera F, Pitts K, et al.
J Allergy Clin Immunol Pract
. 2021 Dec;
10(2):566-576.e6.
PMID: 34890827
Background: The maximum tolerated dose of peanut protein following peanut oral immunotherapy (POIT) is unknown because most research studies have not examined very high thresholds. Objective: To define the maximum...
12.
Kumar P, Liu C, Hsu J, Chacko S, Minard C, Jahoor F, et al.
Clin Transl Med
. 2021 Mar;
11(3):e372.
PMID: 33783984
Background: Oxidative stress (OxS) and mitochondrial dysfunction are implicated as causative factors for aging. Older adults (OAs) have an increased prevalence of elevated OxS, impaired mitochondrial fuel-oxidation (MFO), elevated inflammation,...
13.
Mercedes R, Brown J, Minard C, Tsai C, Devaraj S, Munden M, et al.
Glob Pediatr Health
. 2020 Aug;
7:2333794X20938931.
PMID: 32821773
As liver biopsy in children poses inherent risks, noninvasive measures of liver fibrosis are needed. This was a cross-sectional, liver biopsy validation pilot study of 16 participants evaluating the ability...
14.
Alfaro Cruz L, Minard C, Guffey D, Chumpitazi B, Shulman R
JPEN J Parenter Enteral Nutr
. 2020 Feb;
44(8):1525-1529.
PMID: 32017170
Background: Diet therapies may be recommended for pediatric functional gastrointestinal disorders (FGIDs). However, little is known about the frequency with which diet therapy is recommended in FGIDs. Our aims were...
15.
Lee J, Frey C, Miller J, Minard C, Noor M, Anagnostou A, et al.
Pediatr Allergy Immunol
. 2019 Nov;
31(3):329-332.
PMID: 31765019
No abstract available.
16.
Norris R, Fox E, Reid J, Ralya A, Liu X, Minard C, et al.
Pediatr Blood Cancer
. 2018 Jan;
65(5):e26944.
PMID: 29292843
Background: Ontuxizumab is a humanized IgG monoclonal antibody that targets the cell-surface glycoprotein endosialin (tumor endothelial marker-1[TEM-1]/CD248) found on activated mesenchymal cells and certain tumors. Ontuxizumab binding to endosialin may...
17.
Ahmed S, Guffey D, Minard C, Workeneh B
Am J Emerg Med
. 2016 Jun;
34(8):1552-5.
PMID: 27260551
An estimated 6000 patients who are undocumented immigrants have end-stage renal disease (ESRD) and routinely present to public safety-net hospitals for life-saving emergent dialysis treatments. Because these patients lack a...
18.
Feng Z, Minard C, Raghavan R
Clin Nephrol
. 2015 Apr;
83(5):272-8.
PMID: 25899576
Maternal and fetal outcomes of pregnant women with advanced chronic kidney disease (CKD stage 4 and 5) are not well chronicled. Since 1980, we could locate only five published case...
19.
Siddiqui R, Bell T, Sangi-Haghpeykar H, Minard C, Levison J
AIDS Patient Care STDS
. 2014 Apr;
28(5):248-53.
PMID: 24720630
Guidelines for HIV primary care include visits every 3 months (up to 6 months in those with stable HIV). During pregnancy, women with HIV commonly attend once weekly to once...
20.
Pal R, Basu Thakur P, Li S, Minard C, Rodney G
PLoS One
. 2013 May;
8(5):e63989.
PMID: 23704967
Production of reactive oxygen species (ROS) has been implicated in the pathology of many conditions, including cardiovascular, inflammatory and degenerative diseases, aging, muscular dystrophy, and muscle fatigue. NADPH oxidases (Nox)...